Our story
Leading science should serve people, beautifully.
ArrowBiome began with a simple conviction and a founder’s personal mission to solve stubborn skin challenges. Today we’re a platform biotechnology company at the intersection of science and aspiration: Singapore HQ, European subsidiary, global reach.
Milestones
The road so far.
ArrowBiome incorporated, building on work at SMART (the Singapore-MIT Alliance for Research and Technology), with core lysin IP from MIT.
Seed round raised with Cocoon Capital. ArrowBiome is a Cocoon Capital portfolio company.
Commercial launch of ArcherZyme® and SmartArrow®. First commercial traction and customer conversion cycles begin.
Clinical validation completed for both ArcherZyme® and SmartArrow®.
Expanding IP portfolio, with the most valuable patents wholly owned by ArrowBiome.
in-cosmetics Asia Gold Award for Best New Active Ingredient, awarded for ArcherZyme®.
Continuing EU expansion through ArrowBiome Europe, our Belgian entity, alongside our Singapore HQ.
Manufacturing scale-up underway, and the start of portfolio broadening across new applications.
How we operate
An AI-native biotech.
We did not add AI to a biotech. We are building the company around it, with humans holding the judgment and AI amplifying the work, so a small, senior team delivers the scope of a much larger one.